Financial statements Endokrynologia
Balance sheet data of ENDOKRYNOLOGIA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 65 833,48 | 55 810,50 | 45 709,60 | 36 558,81 | 89 239,66 | 217 845,73 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 65 833,48 | 55 810,50 | 45 709,60 | 36 558,81 | 89 239,66 | 217 845,73 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 65 833,48 | 55 810,50 | 45 709,60 | 36 558,81 | 89 239,66 | 217 845,73 |
| A. Equity | -13 880,61 | -17 816,82 | -62 683,60 | -97 186,32 | -147 188,68 | -90 225,62 |
| B. Liabilities and provisions for liabilities | 79 714,09 | 73 627,32 | 108 393,20 | 133 745,13 | 236 428,34 | 308 071,35 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.